In vivo CAR-T engineering: insights from the 2025 ASH annual meeting
Abstract In vivo chimeric antigen receptor (CAR)-T engineering is a prominent field of research in cancer immunology, in which vectors are used to reprogram endogenous T-cells into CAR-T cells. Viral and nonviral platforms presented at the 67th Annual Meeting of the American Society of Hematology (A...
Na minha lista:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMC
2026-02-01
|
| Serier: | Experimental Hematology & Oncology |
| Fag: | |
| Online adgang: | https://doi.org/10.1186/s40164-026-00762-8 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|